These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 28520799

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preferential recognition of advanced glycation end products by serum antibodies and low-grade systemic inflammation in diabetes mellitus and its complications.
    Raghav A, Ahmad J, Alam K.
    Int J Biol Macromol; 2018 Oct 15; 118(Pt B):1884-1891. PubMed ID: 30009900
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study.
    Neelofar K, Arif Z, Ahmad J, Alam K.
    PLoS One; 2017 Oct 15; 12(2):e0172074. PubMed ID: 28192530
    [Abstract] [Full Text] [Related]

  • 6. Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study.
    Neelofar K, Arif Z, Alam K, Ahmad J.
    Mol Biosyst; 2016 Jul 19; 12(8):2481-9. PubMed ID: 27226040
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe³⁺: its potential role in prompt recognition of diabetes mellitus auto-antibodies.
    Shahab U, Tabrez S, Khan MS, Akhter F, Khan MS, Saeed M, Ahmad K, Srivastava AK, Ahmad S.
    Chem Biol Interact; 2014 Aug 05; 219():229-40. PubMed ID: 24968179
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.
    Neelofar K, Ahmad J.
    Glycoconj J; 2017 Oct 05; 34(5):575-584. PubMed ID: 28812216
    [Abstract] [Full Text] [Related]

  • 13. Albumin Oxidation and Albumin Glycation Discordance During Type 2 Diabetes Therapy: Biological and Clinical Implications.
    Vaishnav MS, Kumari N, Srikanta S, Simha V, Krishnaswamy PR, Balaram P, Bhat N.
    Metab Syndr Relat Disord; 2024 Jun 05; 22(5):372-384. PubMed ID: 38696648
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies.
    Rasheed Z, Ali R.
    Life Sci; 2006 Nov 10; 79(24):2320-8. PubMed ID: 16945391
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of auto-antibodies against D-ribose-glycated-hemoglobin in diabetes mellitus.
    Siddiqui Z, Faisal M, Alatar AR, Ahmad S.
    Glycobiology; 2019 May 01; 29(5):409-418. PubMed ID: 30834437
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.